Skip to Content

Potential to become the best treatment for multiple myeloma in history

As a late breaking, the MAIA-study was presented at EHA 2021 by Thierry Facon, Professor of Haematology, France. In this MEDtalk Facon presents the most important data from MAIA-study. He also give an answer to the following question: Is daratumumab-lenalidomide-dexamethasone the best therapy of multiple myeloma in the history?

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Back to top